1-2 of 2
Martin R. Weihrauch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cyclin D1–Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy

Eisei Kondo, Britta Maecker, Martin R. Weihrauch, Claudia Wickenhauser, WanYong Zeng, Lee M. Nadler, Joachim L. Schultze, Michael S. von Bergwelt-Baildon
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6574–6579.
https://doi.org/10.1158/1078-0432.CCR-08-0825
Published: 16 October 2008
View article titled, Cyclin D1–Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy
Open the PDF for Cyclin D1–Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy in another window
Journal Articles

Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer

Martin R. Weihrauch, Sascha Ansén, Elke Jurkiewicz, Caroline Geisen, Zhinan Xia, Karen S. Anderson, Edith Gracien, Manuel Schmidt, Burghardt Wittig, Volker Diehl, Juergen Wolf, Heribert Bohlen, Lee M. Nadler
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5993–6001.
https://doi.org/10.1158/1078-0432.CCR-05-0018
Published: 22 August 2005
View article titled, Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer
Open the PDF for Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer in another window